Report overview
Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended. Change in bowel habits or blood in stool are the major symptoms of colon cancer. Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation.
This report contains market size and forecasts of Colon Cancer in Global, including the following market information:
Global Colon Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Colon Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Colon Cancer include Bedford Laboratories, Sanofi Aventis, Bayer, GlaxoSmithKline and Teva Pharmaceutical Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Colon Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Colon Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Colon Cancer Market Segment Percentages, by Type, 2021 (%)
Surgery
Chemotherapy
Radiation
Global Colon Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Colon Cancer Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Others
Global Colon Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Colon Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colon Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Colon Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bedford Laboratories
Sanofi Aventis
Bayer
GlaxoSmithKline
Teva Pharmaceutical Industries
